AU2001239941A1 - Beta netrin and uses thereof - Google Patents

Beta netrin and uses thereof

Info

Publication number
AU2001239941A1
AU2001239941A1 AU2001239941A AU3994101A AU2001239941A1 AU 2001239941 A1 AU2001239941 A1 AU 2001239941A1 AU 2001239941 A AU2001239941 A AU 2001239941A AU 3994101 A AU3994101 A AU 3994101A AU 2001239941 A1 AU2001239941 A1 AU 2001239941A1
Authority
AU
Australia
Prior art keywords
netrin
beta
beta netrin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001239941A
Inventor
William Brunken
Robert Burgeson
Dale Hunter
Manuel Koch
Pamela Olson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
General Hospital Corp
Original Assignee
General Hospital Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by General Hospital Corp filed Critical General Hospital Corp
Publication of AU2001239941A1 publication Critical patent/AU2001239941A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Reproductive Health (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Endocrinology (AREA)
  • Pregnancy & Childbirth (AREA)
  • Cardiology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
AU2001239941A 2000-02-29 2001-02-28 Beta netrin and uses thereof Abandoned AU2001239941A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US18581100P 2000-02-29 2000-02-29
US60185811 2000-02-29
US22989300P 2000-09-01 2000-09-01
US60229893 2000-09-01
PCT/US2001/006413 WO2001064837A2 (en) 2000-02-29 2001-02-28 β NETRIN AND USES THEREOF

Publications (1)

Publication Number Publication Date
AU2001239941A1 true AU2001239941A1 (en) 2001-09-12

Family

ID=26881494

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001239941A Abandoned AU2001239941A1 (en) 2000-02-29 2001-02-28 Beta netrin and uses thereof

Country Status (5)

Country Link
US (2) US7390634B2 (en)
EP (1) EP1263767A4 (en)
JP (1) JP2003530831A (en)
AU (1) AU2001239941A1 (en)
WO (1) WO2001064837A2 (en)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2469492C (en) * 2001-12-11 2012-10-16 University Of Medicine And Dentistry Of New Jersey Diagnostic methods for protein profiling
WO2004053066A2 (en) * 2002-12-06 2004-06-24 Millennium Pharmaceuticals, Inc. Methods for the identification, assessment, and treatment of patients with proteasome inhibition therapy
WO2005074556A2 (en) * 2004-01-30 2005-08-18 The General Hospital Corporation Netrin compositions and methods of use thereof
CA2573720A1 (en) 2004-07-14 2006-02-23 University Of Utah Research Foundation Netrin-related compositions and uses
FR2878164B1 (en) * 2004-11-22 2007-03-23 Centre Nat Rech Scient Cnrse NEW USES OF NEOGENINE LIGANDS
FR2878165A1 (en) * 2004-11-22 2006-05-26 Centre Nat Rech Scient New (mutant) netrin-4, netrin-1, netrin-3, anti-idiotypic netrin-4 antibodies, their Fab fragments or nucleotide sequences useful for preventing or treating tumoral or non-tumoral disorders (of angiogenesis)
WO2006054000A2 (en) * 2004-11-22 2006-05-26 Centre National De La Recherche Scientifique Mutated netrin-4, fragments thereof and their use as medicines
WO2008137280A1 (en) * 2007-05-03 2008-11-13 Fox Chase Cancer Center Compositions and methods for altering pancreas or liver function
CA2731296A1 (en) * 2008-07-18 2010-01-21 Centre National De La Recherche Scientifique New mutated netrin 4 proteins, fragments thereof and their uses as drugs
WO2010142040A1 (en) * 2009-06-09 2010-12-16 The Royal Institution For The Advancement Of Learning/Mcgill University Novel netrin derivatives and uses thereof
JPWO2015025770A1 (en) * 2013-08-19 2017-03-02 国立大学法人大阪大学 Method for screening pain suppressing substance and pharmaceutical composition for preventing or treating pain

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5610031A (en) 1993-10-27 1997-03-11 The General Hospital Corporation B1k chain of laminin and methods of use
US5565331A (en) 1993-11-12 1996-10-15 The Regents Of The University Of California Nucleic acids encoding neural axon outgrowth modulators
US5824775A (en) 1996-04-19 1998-10-20 The Regents Of The University Of California Human netrin-1
JP2002521055A (en) * 1998-07-30 2002-07-16 ヒューマン ジノーム サイエンシーズ， インコーポレイテッド 98 human secreted proteins
US6689866B1 (en) 1999-03-09 2004-02-10 Curagen Corporation Polynucleotides and proteins encoded thereby
AU2001283062A1 (en) 2000-08-02 2002-02-13 The Johns Hopkins University Endothelial cell expression patterns

Also Published As

Publication number Publication date
WO2001064837A3 (en) 2002-03-21
US7390634B2 (en) 2008-06-24
EP1263767A4 (en) 2004-12-15
JP2003530831A (en) 2003-10-21
US20040248178A1 (en) 2004-12-09
WO2001064837A2 (en) 2001-09-07
EP1263767A2 (en) 2002-12-11
WO2001064837A8 (en) 2002-05-23
US20030207347A1 (en) 2003-11-06
US7531625B2 (en) 2009-05-12

Similar Documents

Publication Publication Date Title
AU3731600A (en) Composition and structures made therefrom
AU3620600A (en) Skin-marking devices and their use
AU2001250875A1 (en) Anti-microbial and immunostimulating composition
AU6800100A (en) Alpha regions
AU4198299A (en) Compounds and uses thereof
AU5567700A (en) Hair composition
AU2660900A (en) 4-haloalkyl-3-heterocyclylpyridines and 4-haloalkyl-5-heterocyclyl-pyrimidines and their use as repellents
AU2002211717A1 (en) Stresscopins and their uses
AU1403501A (en) Novel composition and use
AU2001292936A1 (en) Octahydro-indolizines and quinolizines and hexahydro-pyrrolizines
AUPQ342599A0 (en) Conjugates and uses thereof
AU2001239941A1 (en) Beta netrin and uses thereof
AU2841801A (en) Triazolotriazinones and the use thereof
AU2001295185A1 (en) Multiplexing-interleaving and demultiplexing-deinterleaving
AU4427201A (en) Noise-abatement structure and its constituting elements
AU1152601A (en) Compositions and their use
AU4198899A (en) Stabilized composition based on pyridinyl-sulfinyl-benzimidazoles and process
AU6125399A (en) Umbrella
AU2001252062A1 (en) Steatosis-modulating factors and uses thereof
AU5979300A (en) Angiopoietin-6 and uses thereof
AU3382800A (en) Secreted proteins and uses thereof
AU2669201A (en) Taccalonolides and their use
AU2002227019A1 (en) Cashcalling and voicemining system
AU1190801A (en) Secreted proteins and uses thereof
AU7674000A (en) Tamoxifen and tamoxifen analogue glycosides and uses thereof